Immuneering Corp - Ordinary Shares Class A

NASDAQ:IMRX   2:58:14 PM EDT
2.95
+0.52 (+21.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immuneering Corp - Ordinary Shares Class A Stock, NASDAQ:IMRX

245 Main Street, 2nd floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.500.8080
Number of Employees: 68

Description

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.